• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

灯盏花素脂质体在犬、兔和大鼠体内的比较药代动力学

Comparative pharmacokinetics of breviscapine liposomes in dogs, rabbits and rats.

作者信息

Lv Wenli, Guo Jianxin, Ping Qineng, Song Yunmei, Li Jin

机构信息

School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

出版信息

Int J Pharm. 2008 Jul 9;359(1-2):118-22. doi: 10.1016/j.ijpharm.2008.03.047. Epub 2008 Apr 11.

DOI:10.1016/j.ijpharm.2008.03.047
PMID:18502062
Abstract

AIM

To compare pharmacokinetics of intravenous breviscapine liposomes in Beagle dogs, rabbits and rats.

METHODS

Six Beagle dogs, 6 rabbits and 12 rats were intravenously administrated with breviscapine liposomes and commercial injection (breviscapine solution) by the crossover design (two periods), respectively. Plasma concentration of scutellarin, the main active component in breviscapine, at different time intervals was determined by reverse phase-HPLC. The pharmacokinetic parameters including area under the curve (AUC), clearance (CL(s)) and volume of distribution (V(c)) were calculated.

RESULTS

The plasma concentration-time profiles were fitted to a two-compartment model. Breviscapine liposomes exhibited significant difference from injection in CL((s)) and AUC, examined by a one-way analysis of variance (ANOVA). With regard to both breviscapine liposomes and commercial injection (free breviscapine), the logarithm values of AUC, CL(s) and V(c) were all related to the logarithm of the body weight by the allometric equation: Y=axW(b).

CONCLUSION

The allometric equation might be applied to extroplate dosage for human from animal data and also for dosage adjustment of breviscapine liposomes in order to achieve same AUC as commercial injection. Compared with the breviscapine solution, breviscapine liposomes delivered more scutellarin into the plasma.

摘要

目的

比较灯盏花素脂质体在比格犬、家兔和大鼠体内的药代动力学。

方法

分别采用交叉设计(两个周期),对6只比格犬、6只家兔和12只大鼠静脉注射灯盏花素脂质体和市售注射液(灯盏花素溶液)。采用反相高效液相色谱法测定灯盏花素中主要活性成分灯盏乙素在不同时间间隔的血浆浓度。计算药代动力学参数,包括曲线下面积(AUC)、清除率(CL(s))和分布容积(V(c))。

结果

血浆浓度-时间曲线符合二室模型。通过单因素方差分析(ANOVA),灯盏花素脂质体在CL((s))和AUC方面与注射液有显著差异。对于灯盏花素脂质体和市售注射液(游离灯盏花素),AUC、CL(s)和V(c)的对数值均通过异速生长方程Y = axW(b)与体重的对数相关。

结论

异速生长方程可用于根据动物数据外推人体剂量,也可用于灯盏花素脂质体的剂量调整,以达到与市售注射液相同的AUC。与灯盏花素溶液相比,灯盏花素脂质体向血浆中递送的灯盏乙素更多。

相似文献

1
Comparative pharmacokinetics of breviscapine liposomes in dogs, rabbits and rats.灯盏花素脂质体在犬、兔和大鼠体内的比较药代动力学
Int J Pharm. 2008 Jul 9;359(1-2):118-22. doi: 10.1016/j.ijpharm.2008.03.047. Epub 2008 Apr 11.
2
[Pharmacokinetics of breviscapine liposomes following intravenous injection in Beagle dogs].灯盏花素脂质体在比格犬静脉注射后的药代动力学
Yao Xue Xue Bao. 2006 Jan;41(1):24-9.
3
Distribution of liposomal breviscapine in brain following intravenous injection in rats.大鼠静脉注射后灯盏花素脂质体在脑中的分布。
Int J Pharm. 2005 Dec 8;306(1-2):99-106. doi: 10.1016/j.ijpharm.2005.09.012. Epub 2005 Nov 8.
4
[Pharmacokinetics of scutellarin in rabbits].[灯盏花素在兔体内的药代动力学]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2003 Dec;20(4):692-4.
5
Study on pharmacokinetics of scutellarin in rabbits.灯盏花素在兔体内的药代动力学研究。
Yao Xue Xue Bao. 2003 Oct;38(10):775-8.
6
Preparation and pharmacokinetics in rabbits of breviscapine unilamellar vesicles.灯盏花素单层脂质体在兔体内的制备及药代动力学研究
Drug Dev Ind Pharm. 2006 Mar;32(3):309-14. doi: 10.1080/03639040500518880.
7
[Study on the pharmacokinetics of scutellarin in dogs].[灯盏花素在犬体内的药代动力学研究]
Yao Xue Xue Bao. 2003 May;38(5):371-3.
8
[Pharmacokinetics of breviscapine in dogs and rabbits following single intravenous administration].灯盏花素单次静脉注射后在犬和兔体内的药代动力学
Zhong Yao Cai. 2005 Oct;28(10):913-6.
9
[Intestinal lymphatic transport of breviscapine orally administered in rat].[大鼠口服灯盏花素后的肠道淋巴转运]
Yao Xue Xue Bao. 2011 Oct;46(10):1262-7.
10
Multivesicular liposome formulation for the sustained delivery of breviscapine.用于灯盏花素持续递送的多囊脂质体制剂。
Int J Pharm. 2005 Sep 14;301(1-2):15-24. doi: 10.1016/j.ijpharm.2005.04.001.

引用本文的文献

1
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management.线粒体适应性在癌症耐药中的作用:普遍性、机制与管理。
J Hematol Oncol. 2022 Jul 18;15(1):97. doi: 10.1186/s13045-022-01313-4.
2
Protective mechanism of Erigeron breviscapus injection on blood-brain barrier injury induced by cerebral ischemia in rats.灯盏花素注射液对脑缺血大鼠血脑屏障损伤的保护作用。
Sci Rep. 2021 Sep 16;11(1):18451. doi: 10.1038/s41598-021-97908-x.
3
Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine.
纳米混悬剂原位凝胶经鼻递药系统用于灯盏花素的研究。
Int J Nanomedicine. 2020 Dec 23;15:10435-10451. doi: 10.2147/IJN.S265659. eCollection 2020.
4
Research tools for extrapolating the disposition and pharmacokinetics of nanomaterials from preclinical animals to humans.从临床前动物外推纳米材料的处置和药代动力学的研究工具。
Theranostics. 2019 May 18;9(11):3365-3387. doi: 10.7150/thno.34509. eCollection 2019.
5
Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.维生素B12修饰的两亲性壳聚糖衍生物增强灯盏花素口服给药疗效以治疗II型糖尿病诱导的视网膜病变
J Nanobiotechnology. 2017 Mar 1;15(1):18. doi: 10.1186/s12951-017-0251-z.
6
Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces.灯盏乙素在大鼠血浆、尿液和粪便中的代谢及药代动力学研究。
Acta Pharmacol Sin. 2011 May;32(5):655-63. doi: 10.1038/aps.2011.11. Epub 2011 Apr 25.